Welcome to LookChem.com Sign In|Join Free

CAS

  • or

923584-14-9

Post Buying Request

923584-14-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1H-Pyrrolo[2,3-b]pyridine, 5-bromo-3-[1-[2-(4-morpholinyl)ethyl]-1H-pyrazol-4-yl]-1-(phenylsulfonyl)-

    Cas No: 923584-14-9

  • No Data

  • No Data

  • No Data

  • SAGECHEM LIMITED
  • Contact Supplier

923584-14-9 Usage

Molecular structure

Heterocyclic compound with a pyrrolopyridine core.

Bromine substitution

Located at the 5 position of the pyrrolopyridine core.

Phenylsulfonyl group

Aromatic group with a sulfonyl functional group attached to the molecule.

Pyrazolyl ring

A five-membered ring containing two nitrogen atoms, which is part of the molecule.

Morpholinyl ethyl side chain

A side chain containing a morpholine ring and an ethyl group attached to the pyrazolyl ring.

Synthetic organic molecule

Likely a human-made compound.

Potential applications

Medicinal chemistry due to the presence of pharmacophores.

Pharmacophores

Functional groups common in drug design, such as the pyrazolyl and sulfonyl groups.

Further research

Necessary for determining specific properties and uses of the compound.

Check Digit Verification of cas no

The CAS Registry Mumber 923584-14-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,3,5,8 and 4 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 923584-14:
(8*9)+(7*2)+(6*3)+(5*5)+(4*8)+(3*4)+(2*1)+(1*4)=179
179 % 10 = 9
So 923584-14-9 is a valid CAS Registry Number.

923584-14-9Upstream product

923584-14-9Relevant articles and documents

7-AZAINDOLE DERIVATIVES AND THEIR USE IN THE INHIBITION OF C-JUN N-TERMINAL KINASE

-

Page/Page column 218-219, (2008/12/08)

The present invention provides a compound of formula (I); or a pharmaceutically acceptable salt thereof, the use of a compound of formula (I) or a pharmaceutically acceptable salt thereof in the inhibition of c-Jun N-terminal kinase (JNK) activity and the use in medicine and particularly in the treatment of neurodegenerative disorders, inflammatory diseases and/or and autoimmune diseases. The invention also provides processes for the manufacture of said compounds of formula (I) or a pharmaceutically acceptable salt thereof and compositions containing them

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 923584-14-9